rs878854549

Variant names:

• chr19-50416650-G-A
• rs878854549
• NM_002691.4:c.2994G>A

Your query was ambiguous. Multiple possible variants found:

• chr19-50416650-G-A
• chr19-50416650-G-C
• chr19-50416650-G-T

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 2P and 11B. PM2 BP4_Moderate BP6_Very_Strong BP7

The NM_002691.4(POLD1):​c.2994G>A​(p.Lys998Lys) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

• Frequency:
  • Genomes: not found (cov: 34)
  • Exomes 𝑓: 0.0 (0 hom.)
  • Failed GnomAD Quality Control
• Consequence: POLD1 NM_002691.4 synonymous
• Clinical Significance: Likely benign criteria provided, multiple submitters, no conflicts B:2
• Conservation: PhyloP100: 1.90
• Publications: 0 publications found

Genes affected

POLD1 (HGNC:9175): (DNA polymerase delta 1, catalytic subunit) This gene encodes the 125-kDa catalytic subunit of DNA polymerase delta. DNA polymerase delta possesses both polymerase and 3' to 5' exonuclease activity and plays a critical role in DNA replication and repair. Alternatively spliced transcript variants have been observed for this gene, and a pseudogene of this gene is located on the long arm of chromosome 6. [provided by RefSeq, Mar 2012]

POLD1 Gene-Disease associations (from GenCC):

• POLD1-related polyposis and colorectal cancer syndrome

  Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
• colorectal cancer, susceptibility to, 10

  Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Genomics England PanelApp
• mandibular hypoplasia-deafness-progeroid syndrome

  Inheritance: AD, AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Genomics England PanelApp, Ambry Genetics, Orphanet, G2P
• Polymerase proofreading-related adenomatous polyposis

  Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
• immunodeficiency 120

  Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics
• non-severe combined immunodeficiency due to polymerase delta deficiency

  Inheritance: AR Classification: LIMITED Submitted by: ClinGen

ENSG00000142539 (HGNC:):

ACMG classification

Our verdict: Benign. The variant received -9 ACMG points.

• PM2: Very rare variant in population databases, with high coverage
• BP4: Computational evidence support a benign effect (REVEL=0.027).
• BP6: Variant 19-50416650-G-A is Benign according to our data. Variant chr19-50416650-G-A is described in CliVar as Likely_benign. Clinvar id is 469319.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-50416650-G-A is described in CliVar as Likely_benign. Clinvar id is 469319.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-50416650-G-A is described in CliVar as Likely_benign. Clinvar id is 469319.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-50416650-G-A is described in CliVar as Likely_benign. Clinvar id is 469319.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-50416650-G-A is described in CliVar as Likely_benign. Clinvar id is 469319.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-50416650-G-A is described in CliVar as Likely_benign. Clinvar id is 469319.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-50416650-G-A is described in CliVar as Likely_benign. Clinvar id is 469319.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-50416650-G-A is described in CliVar as Likely_benign. Clinvar id is 469319.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-50416650-G-A is described in CliVar as Likely_benign. Clinvar id is 469319.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-50416650-G-A is described in CliVar as Likely_benign. Clinvar id is 469319.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-50416650-G-A is described in CliVar as Likely_benign. Clinvar id is 469319.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-50416650-G-A is described in CliVar as Likely_benign. Clinvar id is 469319.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-50416650-G-A is described in CliVar as Likely_benign. Clinvar id is 469319.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-50416650-G-A is described in CliVar as Likely_benign. Clinvar id is 469319.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-50416650-G-A is described in CliVar as Likely_benign. Clinvar id is 469319.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-50416650-G-A is described in CliVar as Likely_benign. Clinvar id is 469319.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-50416650-G-A is described in CliVar as Likely_benign. Clinvar id is 469319.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-50416650-G-A is described in CliVar as Likely_benign. Clinvar id is 469319.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-50416650-G-A is described in CliVar as Likely_benign. Clinvar id is 469319.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-50416650-G-A is described in CliVar as Likely_benign. Clinvar id is 469319.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-50416650-G-A is described in CliVar as Likely_benign. Clinvar id is 469319.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-50416650-G-A is described in CliVar as Likely_benign. Clinvar id is 469319.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-50416650-G-A is described in CliVar as Likely_benign. Clinvar id is 469319.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-50416650-G-A is described in CliVar as Likely_benign. Clinvar id is 469319.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-50416650-G-A is described in CliVar as Likely_benign. Clinvar id is 469319.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-50416650-G-A is described in CliVar as Likely_benign. Clinvar id is 469319.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-50416650-G-A is described in CliVar as Likely_benign. Clinvar id is 469319.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-50416650-G-A is described in CliVar as Likely_benign. Clinvar id is 469319.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-50416650-G-A is described in CliVar as Likely_benign. Clinvar id is 469319.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-50416650-G-A is described in CliVar as Likely_benign. Clinvar id is 469319.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-50416650-G-A is described in CliVar as Likely_benign. Clinvar id is 469319.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-50416650-G-A is described in CliVar as Likely_benign. Clinvar id is 469319.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-50416650-G-A is described in CliVar as Likely_benign. Clinvar id is 469319.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-50416650-G-A is described in CliVar as Likely_benign. Clinvar id is 469319.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-50416650-G-A is described in CliVar as Likely_benign. Clinvar id is 469319.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-50416650-G-A is described in CliVar as Likely_benign. Clinvar id is 469319.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-50416650-G-A is described in CliVar as Likely_benign. Clinvar id is 469319.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-50416650-G-A is described in CliVar as Likely_benign. Clinvar id is 469319.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-50416650-G-A is described in CliVar as Likely_benign. Clinvar id is 469319.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-50416650-G-A is described in CliVar as Likely_benign. Clinvar id is 469319.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-50416650-G-A is described in CliVar as Likely_benign. Clinvar id is 469319.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-50416650-G-A is described in CliVar as Likely_benign. Clinvar id is 469319.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-50416650-G-A is described in CliVar as Likely_benign. Clinvar id is 469319.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-50416650-G-A is described in CliVar as Likely_benign. Clinvar id is 469319.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-50416650-G-A is described in CliVar as Likely_benign. Clinvar id is 469319.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-50416650-G-A is described in CliVar as Likely_benign. Clinvar id is 469319.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
• BP7: Synonymous conserved (PhyloP=1.9 with no splicing effect.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	MANE	Protein	UniProt
POLD1	NM_002691.4	c.2994G>A	p.Lys998Lys	synonymous_variant	Exon 24 of 27	ENST00000440232.7	NP_002682.2

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	TSL	MANE	Protein	Appris	UniProt
POLD1	ENST00000440232.7	c.2994G>A	p.Lys998Lys	synonymous_variant	Exon 24 of 27	1	NM_002691.4	ENSP00000406046.1
ENSG00000142539	ENST00000599632.1	c.201G>A	p.Lys67Lys	synonymous_variant	Exon 3 of 10	5		ENSP00000473233.1

Frequencies

GnomAD3 genomes Cov.: 34

GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0 AN: 1412832 Hom.: 0 Cov.: 34 AF XY: 0.00 AC XY: 0 AN XY: 699502

African (AFR) AF: 0.00 AC: 0 AN: 32288

American (AMR) AF: 0.00 AC: 0 AN: 38408

Ashkenazi Jewish (ASJ) AF: 0.00 AC: 0 AN: 25370

East Asian (EAS) AF: 0.00 AC: 0 AN: 37052

South Asian (SAS) AF: 0.00 AC: 0 AN: 80886

European-Finnish (FIN) AF: 0.00 AC: 0 AN: 43506

Middle Eastern (MID) AF: 0.00 AC: 0 AN: 4988

European-Non Finnish (NFE) AF: 0.00 AC: 0 AN: 1091684

Other (OTH) AF: 0.00 AC: 0 AN: 58650

GnomAD4 genome Cov.: 34

ClinVar

Significance: Likely benign

Submissions summary: Benign:2

Revision: criteria provided, multiple submitters, no conflicts

Submissions by phenotype

Colorectal cancer, susceptibility to, 10 Benign:1

Oct 13, 2022

Labcorp Genetics (formerly Invitae), Labcorp

Significance: Likely benign

Review Status: criteria provided, single submitter

Collection Method: clinical testing

- -

Hereditary cancer-predisposing syndrome Benign:1

Oct 24, 2024

Ambry Genetics

Significance: Likely benign

Review Status: criteria provided, single submitter

Collection Method: clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name	Calibrated prediction	Score	Prediction
BayesDel_noAF	Benign	-0.58
CADD	Benign	9.8
DANN	Benign	0.85
PhyloP100		1.9
RBP_binding_hub_radar		0.0
RBP_regulation_power_radar		1.8
Mutation Taster		=100/0	polymorphism

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.0		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Other links and lift over

dbSNP: rs878854549; hg19: chr19-50919907;